Search Results for Compounding Pharmacy

Showing 1 – 25  of 26

FDA Warns Compounding Pharmacy, Finds Wood in Drug Sample By Zachary Brennan - Published 22 August 2017

The US Food and Drug Administration (FDA) earlier this month sent a warning letter to a Folcroft, PA-based compounding drug facility run by ImprimisRx after uncovering adulterated products and insanitary conditions.

Categories: News, US, FDA, Compliance, Drugs

Tags: ImprimisRx, compounding drugs, compounding pharmacy

FDA Hits Two Compounders for Making J&J Drug That Lacked US Approval By Alexander Gaffney, RAC - Published 18 March 2014

Categories: US, FDA

Tags: CPG 460.200, DQSA, Compounding Pharmacy, Compounding, warning letter, Latest News

Warning Letter Resurrects Issue of Makena and FDA's Use of Enforcement Discretion By Alexander Gaffney, RAC - Published 13 March 2014

Categories: US, FDA

Tags: Pharmaceutical Compounding, Makena, Compounding Pharmacy, Compounding, warning letter, Latest News

FDA Warns Three Compounding Pharmacies for Unsanitary Conditions By Alexander Gaffney, RAC - Published 04 March 2014

Categories: US, FDA

Tags: DQSA, Pharmaceutical Compounding, Compounding Pharmacy, Compounding, warning letter, Latest News

FDA Cites New Authorities in First Warning Letter to Compounding Pharmacy in Six Months By Alexander Gaffney, RAC - Published 28 January 2014

Categories: US

Tags: DQSA, Compounding Pharmacy, warning letter, Latest News

Hamburg Takes Peer-Pressure Approach in Advocating for Safer Compounding Practices By Alexander Gaffney, RAC - Published 10 January 2014

Categories: US, FDA, CDER

Tags: Pharmaceutical Compounding, Compounding Pharmacy, Compounding, Margaret Hamburg

As Compounding Framework Takes Shape, So Does Influential Advisory Committee By Alexander Gaffney, RAC - Published 10 January 2014

Categories: US, FDA

Tags: Difficult-to-Compound, Pharmaceutical Compounding, Compounding Pharmacy, Compounding

As FDA Begins to Implement DQSA, Questions About Enforcement Discretion go Unanswered By Alexander Gaffney, RF News Editor - Published 03 December 2013

Categories: US, FDA

Tags: Pharmaceutical Compounding, Compounding Pharmacy, Compounding

FDA Prepares Compounding Blacklist of Banned Products By Alexander Gaffney, RF News Editor - Published 03 December 2013

Categories: US, FDA

Tags: Difficult-to-Compound, Pharmaceutical Compounding, Compounding Pharmacy, Compounding, Latest News

As Battle Rages over Semantics of Compounding Pharmacies, Missouri Calls One an Executioner By Alexander Gaffney, RF News Editor - Published 20 November 2013

Categories: US, FDA

Tags: Pentobarbital, Compounding Pharmacy, Compounding, Death Penalty, Latest News, execution

Inspection of Contract Testing Lab Raises Product Quality Questions for Dozens of Companies By Alexander Gaffney, RF News Editor - Published 22 August 2013

Categories: US, FDA

Tags: Pharmaceutical Compounding, Compounding Pharmacy, Compounding

With Recall Options Limited in Compounding Case, FDA Turns to Public Shaming to Protect Consumers By Alexander Gaffney, RF News Editor - Published 19 August 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding

Watchdog Group: FDA Failed to Shut Down Compounder Earlier, at Blame for Outbreak of Infections By Alexander Gaffney, RF News Editor - Published 14 August 2013

Categories: US, FDA

Tags: Infections, Compounding Pharmacy, Compounding, Sterility, Sterile, Public Citizen, Recall, Latest News

Compounded Products Linked with Potential Deadly Infections, Putting New Pressure on FDA, Congress By Alexander Gaffney, RF News Editor - Published 12 August 2013

Categories: US, FDA

Tags: Infections, Compounding Pharmacy, Compounding, Sterility, Sterile, Recall, Latest News

Rare Letter to Compounding Pharmacy Shows FDA Demanding Recall of Potentially Unsterile Products By Alexander Gaffney, RF News Editor - Published 07 August 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, Recall

GAO Report Gives Credence to FDA's Pharmaceutical Compounding Claims By Alexander Gaffney, RF News Editor - Published 01 August 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, Report, Latest News, GAO, Congress, pharmaceutical, drug

Pharmacy's Penicillin Manufacturing Problems Relate to Recently-Released Guidance Document By Alexander Gaffney, RF News Editor - Published 28 June 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, 483

Spiders, Non-Sterile Practices Lead to Warning for Compounder at Center of Recall By Alexander Gaffney, RF News Editor - Published 13 June 2013

Categories: US, FDA

Tags: Form 483, Compounding Pharmacy

FDA Testing Confirms Fungal, Bacterial Contamination of Yet Another Pharmacy's Products By Alexander Gaffney, RF News Editor - Published 07 June 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, Sterility, MedWatch, Latest News, Warning

Disturbing Parallels Seen in New Compounding Pharmacy Warning By Alexander Gaffney, RF News Editor - Published 28 May 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, Sterility, MedWatch, Latest News, Warning

Compounding Pharmacy Chain Hit with Record Six Form-483s By Alexander Gaffney, RF News Editor - Published 06 May 2013

Categories: US, FDA

Tags: Pharmaceutical Compounding, Compounding Pharmacy, 483

Compounding Pharmacy Recalls all Products after FDA Finds Microbial Contamination in Vials By Alexander Gaffney, RF News Editor - Published 22 April 2013

Categories: US, FDA

Tags: Compounding Pharmacy, Compounding, 483, Contamination, Recall, Latest News

Sterility Issues Found at Second Compounder as FDA Anticipates New Drug Shortages By Alexander Gaffney, RF News Editor - Published 01 November 2012

Categories: FDA

Tags: Ameridose, Meningitis, Compounders, Compounding Pharmacy, Compounding, Latest News, regulation

State and Local Officials Launch Criminal Probe of Compounder as FDA Criticized By Alexander Gaffney, RF News Editor - Published 25 October 2012

Categories: FDA

Tags: Meningitis, Compounders, Compounding Pharmacy, Compounding, Latest News, regulation

Meningitis Outbreak Places Spotlight on FDA's Regulation of Compounding Pharmacies By Alexander Gaffney - Published 05 October 2012

Categories: FDA

Tags: Meningitis, Compounders, Compounding Pharmacy, Compounding, Latest News, regulation